otic-202501240001869453FALSE00018694532025-01-242025-01-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 24, 2025
BLUE OWL TECHNOLOGY INCOME CORP.
(Exact name of Registrant as Specified in Its Charter)
| | | | | | | | | | | | | | |
| | | | |
Maryland | | 814-01445 | | 87-1346173 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | | | | | | |
| | |
399 Park Avenue New York, NY | | 10022 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (212) 419-3000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
| | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | | | | |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | | | | |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | | | | |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| None | | None | | None |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.02. Unregistered Sale of Equity Securities
As of January 2, 2025, Blue Owl Technology Income Corp. (the “Company,” “we” or “us”) sold unregistered shares of its Class I common stock to feeder vehicles primarily created to hold the Company’s Class I shares. The offer and sale of these Class I shares was exempt from the registration provisions of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) and/or Regulation S thereunder (the “Private Offering”). The following table details the shares sold:
| | | | | | | | | | | | | | |
| Date of Unregistered Sale | | Approximate Number of Shares of Class I Common Stock | | Consideration |
As of January 2, 2025 (number of shares finalized on January 24, 2025) | | 4,194,151 | | | $ | 43,703,055 | |
Item 8.01. Other Events.
Distribution
On November 5, 2024, the Company’s board of directors declared the following monthly distributions payable on or before February 28, 2025, to shareholders of record as of January 31, 2025.
| | | | | | | | | | | | | | | | | | | | |
Class of Common Shares | | Gross Distributions | | Shareholder Servicing Fee (1) | | Net Distributions (1) |
Class S | | $ | 0.074775 | | | $ | 0.007530 | | | $ | 0.067245 | |
Class D | | $ | 0.074775 | | | $ | 0.002215 | | | $ | 0.072560 | |
Class I | | $ | 0.074775 | | | $ | 0.000000 | | | $ | 0.074775 | |
(1) Based on October 31, 2024 net asset value.
Status of the Offering
The Company is currently publicly offering on a continuous basis up to $5.0 billion (the “Current Offering”) in shares of Class S, Class D and Class I common stock (the “Shares”) and previously offered on a continuous basis up to $5.0 billion (the “Initial Offering” and together with the Current Offering, the “Offering”) in Class S, Class D and Class I Shares. Additionally, the Company has sold unregistered Shares as part of the Private Offering. The following table lists the Shares issued and total consideration for both the Offering and the Private Offering as of the date of this filing. The table below does not include Shares issued through the Company’s distribution reinvestment plan.
| | | | | | | | | | | | | | |
| Offering | | Common Shares Issued | | Total Consideration |
| Class S Shares | | 73,237,984 | | | $ | 755,474,563 | |
| Class D Shares | | 2,913,635 | | | 29,704,508 | |
| Class I Shares | | 32,304,798 | | | 330,838,325 | |
| Private Offering | | | | |
| Class I Shares | | 209,914,241 | | | 2,141,987,728 | |
| Total Offering and Private Offering* | | 318,370,658 | | | $ | 3,258,005,124 | |
*Includes seed capital of $1,000 contributed by Blue Owl Technology Credit Advisors LLC, an affiliate of Blue Owl Technology Credit Advisors II LLC (the “Adviser”), in September 2021 and approximately $50.0 million in gross proceeds raised from entities affiliated with the Adviser.
Recent Blue Owl Credit Transaction Highlights1
In December 2024, Blue Owl Capital Inc.’s (“Blue Owl”) Credit platform closed on a $4.8 billion senior secured credit facility to support Novo Holdings’ acquisition of Catalent, a global development and manufacturing organization for the pharma & biotech industries. Blue Owl is one of the largest lenders in the transaction and serves as the joint lead arranger.
| | | | | |
| |
| 1 | The information provided, including dollar amounts, represents the aggregated investment of all participating vehicles, including the Company, that are part of Blue Owl’s Credit platform. The final dollar amount of the Company’s portion of the investment will be determined and disclosed in the Company’s future periodic reports. |
January 2, 2025 Public Offering Price
In accordance with the Company’s share pricing policy, we intend to sell our shares on the first business day of each month at a net offering price that we believe reflects the net asset value per share at the end of the preceding month. The January 2, 2025 public offering price for each of our share classes is equal to such class’s NAV per share as of December 31, 2024, plus applicable maximum upfront sales load.
| | | | | |
| Net Asset Value (per share) |
| Class S | $10.42 |
| Class D | $10.42 |
| Class I | $10.42 |
The average debt-to-equity leverage ratio during the month-to-date period ended December 31, 2024 was 0.68x. The table below summarizes the company’s committed debt capacity and drawn amounts as of December 31, 2024.
| | | | | | | | | | | | | | |
| ($ in thousands) | | Aggregate Principal Committed | | Outstanding Principal |
| Revolving Credit Facility | | $ | 1,000,000 | | | $ | 499,989 | |
| SPV Asset Facility I | | 750,000 | | | 445,000 | |
| SPV Asset Facility II | | 500,000 | | | 475,000 | |
| SPV Asset Facility III | | 550,000 | | | 315,000 | |
| Athena CLO III | | 270,000 | | | 270,000 | |
| Series 2023A Notes | | 100,000 | | | 100,000 | |
| Series 2023B Notes - Tranche A | | 100,000 | | | 100,000 | |
| Series 2023B Notes - Tranche B | | 75,000 | | | 75,000 | |
| Total Debt | | $ | 3,345,000 | | | $ | 2,279,989 | |
Of the Company’s committed debt capacity, $2.2 billion (95.4%) is in secured floating rate leverage based on drawn amounts.
Portfolio Update
As of December 31, 2024, we had debt investments in 163 portfolio companies with an aggregate par value of $5.0 billion. As of December 31, 2024, based on par value, our portfolio consisted of 90.8% first lien debt investments, 3.4% second lien debt investments, 1.2% unsecured debt investments, 3.4% preferred equity investments and 1.2% common equity investments. As of December 31, 2024, 99.1% of the debt investments based on par value in our
portfolio were at floating rates. The table below describes investments by industry composition based on par value, excluding equity investments, as of December 31, 2024.
| | | | | | | | | | | | | | |
| Industry | | Par ($ in thousands) | | % of Par |
| Systems Software | | $ | 813,982 | | | 16.3 | % |
| Health Care Technology | | 623,191 | | | 12.5 | % |
| Application Software | | 615,829 | | | 12.3 | % |
| Insurance | | 368,658 | | | 7.4 | % |
| Professional Services | | 325,993 | | | 6.5 | % |
| Diversified Financial Services | | 297,264 | | | 6.0 | % |
| IT Services | | 245,910 | | | 4.9 | % |
| Health Care Providers & Services | | 215,178 | | | 4.3 | % |
| Commercial Services & Supplies | | 159,214 | | | 3.2 | % |
| Food & Staples Retailing | | 157,507 | | | 3.2 | % |
| Diversified Consumer Services | | 138,917 | | | 2.8 | % |
| Life Sciences Tools & Services | | 119,401 | | | 2.4 | % |
| Buildings & Real Estate | | 95,682 | | | 1.9 | % |
| Health Care Equipment & Supplies | | 85,583 | | | 1.7 | % |
| Real Estate Management & Development | | 71,058 | | | 1.4 | % |
| Entertainment | | 70,064 | | | 1.4 | % |
| Banks | | 63,858 | | | 1.3 | % |
| Hotels, Restaurants & Leisure | | 52,632 | | | 1.1 | % |
| Containers & Packaging | | 49,968 | | | 1.0 | % |
| Equity Real Estate Investment Trusts (REITs) | | 49,616 | | | 1.0 | % |
| Aerospace & Defense | | 48,448 | | | 1.0 | % |
| Machinery | | 36,211 | | | 0.7 | % |
| Beverages | | 36,016 | | | 0.7 | % |
| Industrial Conglomerates | | 35,339 | | | 0.7 | % |
| Media | | 34,639 | | | 0.7 | % |
| Consumer Finance | | 32,666 | | | 0.7 | % |
| Construction & Engineering | | 29,910 | | | 0.6 | % |
| Internet & Direct Marketing Retail | | 26,180 | | | 0.5 | % |
| Food Products | | 20,227 | | | 0.4 | % |
| Diversified Telecommunication Services | | 16,231 | | | 0.3 | % |
| Multiline Retail | | 14,869 | | | 0.3 | % |
| Water Utilities | | 10,167 | | | 0.2 | % |
| Pharmaceuticals | | 10,003 | | | 0.2 | % |
| Capital Markets | | 7,797 | | | 0.2 | % |
| Specialty Retail | | 7,325 | | | 0.1 | % |
| Building Products | | 6,349 | | | 0.1 | % |
| Total | | $ | 4,991,882 | | | 100.0 | % |
Past performance is not necessarily indicative of future performance, and there can be no assurance that we will achieve comparable investment results, or that any targeted returns will be met.
Statements contained herein that are not historical facts are based on current expectations, estimates, projections, opinions, and/or beliefs of our management. Such statements involve known and unknown risks, uncertainties, and other factors, and undue reliance should not be placed thereon. Certain information contained herein constitutes “forward-looking statements,” which can be identified by the use of terms such as “may”, “will”, “should”, “expect”, “project”, “estimate”, “intend”, “continue”, “target”, or “believe” (or the negatives thereof) or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or our actual performance may differ materially from those reflected or contemplated in such forward-looking statements. As a result, investors should not rely on such forward-looking statements in making their investment decisions.
The estimates presented above are based on management’s preliminary determinations only and, consequently, the data set forth in our Form 10-Q or 10-K may differ from these estimates, and any such differences may be material. In addition, the information presented above does not include all of the information regarding our financial condition and results of operations that may be important to investors. As a result, investors are cautioned not to place undue reliance on the information presented above. The information presented above is based on management’s current expectations that involve substantial risk and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such information. We assume no duty to update these preliminary estimates except as required by law.
Neither KPMG LLP, our independent registered public accounting firm, nor any other independent accountants, have audited, reviewed, compiled or performed procedures with respect to the preliminary financial data contained herein. Accordingly, KPMG LLP does not express an opinion or any form of assurance with respect thereto and assumes no responsibility for, and disclaims any association with, this information.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be singed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | | | | | | | | | | |
| | | | Blue Owl Technology Income Corp. |
| | | | | |
Dated: | January 27, 2025 | | | By: | /s/ Jonathan Lamm |
| | | | | Name: Jonathan Lamm |
| | | | | Title: Chief Operating Officer and Chief Financial Officer |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |